Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
3(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
3
20%
Ph not_applicable
4
27%
Ph phase_1
1
7%
Ph phase_4
2
13%

Phase Distribution

4

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
3(30.0%)
Phase 1Safety & dosage
1(10.0%)
Phase 4Post-market surveillance
2(20.0%)
N/ANon-phased studies
4(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(3)
Completed(11)
Other(1)

Detailed Status

Completed11
Recruiting2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (30.0%)
Phase 11 (10.0%)
Phase 42 (20.0%)
N/A4 (40.0%)

Trials by Status

completed1173%
recruiting213%
active_not_recruiting17%
unknown17%

Recent Activity

3 active trials
Showing 5 of 15
recruitingnot_applicable

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

NCT04047264
active_not_recruiting

Cerebral Protection in Aortic Arch Surgery

NCT04966247
recruitingearly_phase_1

Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma

NCT05717153
completedearly_phase_1

Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors

NCT02338037
completed

Developing and Validating Blood and Imaging BIOmarkers of AXonal Injury Following Traumatic Brain Injury

NCT03534154
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT04047264Not Applicable

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

Recruiting
NCT04966247

Cerebral Protection in Aortic Arch Surgery

Active Not Recruiting
NCT05717153Early Phase 1

Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma

Recruiting
NCT02338037Early Phase 1

Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors

Completed
NCT03534154

Developing and Validating Blood and Imaging BIOmarkers of AXonal Injury Following Traumatic Brain Injury

Completed
NCT03700346Not Applicable

Muscle Lactate and Lactate to Pyruvate Ratio Clearance in Septic Shock Patients

Completed
NCT03599180

Clinical Protocol of Sensitized Acupoint Changes in Knee Osteoarthritis Patients

Completed
NCT01234740Phase 1

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

Completed
NCT02846818Not Applicable

Cerebral Energy State in Cardiac Surgery

Completed
NCT01817400Early Phase 1

Mediators of Abnormal Reproductive Function in Obesity (MARO)

Completed
NCT02364219Not Applicable

Impact of Prewarming on Perioperative Body Core Temperature and the Outcomes of Cytoreductive- and Major Open Abdominal Surgery: A Randomised Trial

Unknown
NCT01539330Phase 4

Assessment of Target Site Pharmacokinetics of Voriconazole in Healthy Volunteers During Sequence Therapy

Completed
NCT00658866Phase 4

Target Site Pharmacokinetics of Ertapenem After Multiple Doses in Diabetes Patients With Soft Tissue Infection

Completed
NCT00499954

Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics

Completed
NCT00463645

Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients

Completed

All 15 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
15